CFO Alam Kamran Sells 1,655 Shares in Feb‑4 Tax‑Cover Deal, Raising $7.5 M While Holding 60% of Taysha Gene Therapies’ Float.
Alam Kamran’s Feb. 4 sell‑to‑cover of 1,655 Taysha Gene Therapies shares reveals strategic cash‑management, not a red flag, for investors.
3 minutes to read